Abstract：Objective To study the distribution, drug resistance, and biofilm characteristics of carbapenem-resistant Acinetobacter baumannii (CRAB) isolated from hospitalized children, providing a reference for the prevention and treatment of CRAB infections in hospitalized children. Methods Forty-eight CRAB strains isolated from January 2019 to December 2022 were classified into epidemic and sporadic strains using repetitive extragenic palindromic sequence-based polymerase chain reaction. The drug resistance, biofilm phenotypes, and gene carriage of these two types of strains were compared. Results Both the 22 epidemic strains and the 26 sporadic strains were producers of Class D carbapenemases or extended-spectrum β-lactamases with downregulated outer membrane porins, harboring the VIM, OXA-23, and OXA-51 genes. The biofilm formation capability of the sporadic strains was stronger than that of the epidemic strains (P<0.05). Genes related to biofilm formation, including Bap, bfs, OmpA, CsuE, and intI1, were detected in both epidemic and sporadic strains, with a higher detection rate of the intI1 gene in epidemic strains (P<0.05). Conclusions CRAB strains are colonized in the hospital, with sporadic strains having a stronger ability to form biofilms, suggesting the potential for forming new clonal transmissions in the hospital. Continuous monitoring of the epidemic trends of CRAB and early warning of the distribution of epidemic strains are necessary to reduce the risk of CRAB infections in hospitalized children.
LI Yun-Yun,LIU Hou-Chang,WANG Hai-Ping et al. Characteristics of drug resistance and biofilm formation in carbapenem-resistant Acinetobacter baumannii in hospitalized children[J]. CJCP, 2024, 26(4): 358-364.
Aliramezani A, Douraghi M, Hajihasani A, et al. Clonal relatedness and biofilm formation of OXA-23-producing carbapenem resistant Acinetobacter baumannii isolates from hospital environment[J]. Microb Pathog, 2016, 99: 204-208. PMID: 27569533. DOI: 10.1016/j.micpath.2016.08.034.
Koeleman JG, van der Bijl MW, Stoof J, et al. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii[J]. Infect Control Hosp Epidemiol, 2001, 22(5): 284-288. PMID: 11428438. DOI: 10.1086/501901.
Vila J, Marcos MA, Jimenez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex[J]. J Med Microbiol, 1996, 44(6): 482-489. PMID: 8636966. DOI: 10.1099/00222615-44-6-482.
Abouelfetouh A, Torky AS, Aboulmagd E. Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt[J]. Antimicrob Resist Infect Control, 2019, 8: 185. PMID: 31832185. PMCID: PMC6868752. DOI: 10.1186/s13756-019-0611-6.
Stepanovi? S, Vukovi? D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci[J]. APMIS, 2007, 115(8): 891-899. PMID: 17696944. DOI: 10.1111/j.1600-0463.2007.apm_630.x.
Ziegler KM, Haywood JD, Sontag MK, et al. Application of the new centers for disease control and prevention surveillance criteria for ventilator-associated events to a cohort of PICU patients identifies different patients compared with the previous definition and physician diagnosis[J]. Crit Care Med, 2019, 47(7): e547-e554. PMID: 30985451. PMCID: PMC7089756. DOI: 10.1097/CCM.0000000000003766.
Zhu Y, Zhang X, Wang Y, et al. Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children's medical centre in eastern China[J]. Ann Clin Microbiol Antimicrob, 2022, 21(1): 47. PMID: 36335338. PMCID: PMC9637306. DOI: 10.1186/s12941-022-00536-0.
Wang X, Du Z, Huang W, et al. Outbreak of multidrug-resistant Acinetobacter baumannii ST208 producing OXA-23-like carbapenemase in a children's hospital in Shanghai, China[J]. Microb Drug Resist, 2021, 27(6): 816-822. PMID: 33185494. DOI: 10.1089/mdr.2019.0232.
Lee YT, Kuo SC, Chiang MC, et al. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii[J]. Antimicrob Agents Chemother, 2012, 56(2): 1124-1127. PMID: 22083478. PMCID: PMC3264228. DOI: 10.1128/AAC.00622-11.
Khoshnood S, Savari M, Abbasi Montazeri E, et al. Survey on genetic diversity, biofilm formation, and detection of colistin resistance genes in clinical isolates of Acinetobacter baumannii[J]. Infect Drug Resist, 2020, 13: 1547-1558. PMID: 32547124. PMCID: PMC7266307. DOI: 10.2147/IDR.S253440.
Kishii K, Hamada M, Aoki K, et al. Differences in biofilm formation and transcription of biofilm-associated genes among Acinetobacter baumannii clinical strains belonging to the international clone II lineage[J]. J Infect Chemother, 2020, 26(7): 693-698. PMID: 32249162. DOI: 10.1016/j.jiac.2020.02.017.
Al-Shamiri MM, Zhang S, Mi P, et al. Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility[J]. Microb Pathog, 2021, 155: 104922. PMID: 33932545. DOI: 10.1016/j.micpath.2021.104922.
